Incannex updates on IHL-42X dosing, new patent, and $70 million cash positionSep 9Clinical readoutIHL-42XIncannex Healthcare Ltd
Incannex doses first patient in Phase 2 DReAMzz trial of IHL-42XAug 25Regulatory milestoneIHL-42XIncannex Healthcare Ltd
Incannex begins screening patients in Phase 2 sleep apnea trial of IHL-42XJul 23Regulatory milestoneIHL-42XIncannex Healthcare Ltd
Sign inSign in